Helen Louise Collins
CIK 1701247 · CHIEF MEDICAL OFFICER · last filed 2026-06-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$510.6K
Companies
5
Total Filings
45
Lifetime Open-Market Net
-$4.89M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KURA | Director | — | $9.05 | — | $0 | 6 | 2026-06-04 |
| IMRA | CHIEF MEDICAL OFFICER | 30,000 | $17.02 | $510.6K | -$4.89M | 13 | 2026-05-20 |
| IO Biotech, Inc. (IOBT) Delisted | Director | — | $0.05 | — | $0 | 3 | 2025-06-06 |
| FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | EVP and Chief Medical Officer | 69,547 | $38.00 | $2.64M | $0 | 9 | 2021-04-19 |
| FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | EVP and Chief Medical Officer | 44,298 | $178.75 | $7.92M | $0 | 14 | 2019-09-04 |
Recent Filings · Page 4 of 5
45 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-02-06 | FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Tax (F) | −5,345 | -$27.4K | EDGAR |
| 2019-09-04 | FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Tax (F) | −496 | -$2.7K | EDGAR |
| 2019-08-22 | FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Grant (A) | +5,000 | $0 | EDGAR |
| 2019-06-26 | FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-02-27 | FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Mixed | +8,823 | -$14.1K | EDGAR |
| 2019-02-07 | FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Tax (F) | −3,196 | -$36.5K | EDGAR |
| 2018-10-02 | FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Mixed | +1,938 | -$26.5K | EDGAR |
| 2018-09-05 | FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Tax (F) | −496 | -$6.9K | EDGAR |
| 2018-06-26 | FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Tax (F) | −1,240 | -$21.6K | EDGAR |
| 2018-03-22 | FIVE PRIME THERAPEUTICS, INC. (XLRN) Delisted | Tax (F) | −827 | -$13.4K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.